The role for decorin in delayed-type hypersensitivity

Journal of Immunology

Volumn 187, Issue 11, 2011, Pages 6108-6119

  Seidler, Daniela G ^a   Mohamed, Negia A ^a   Bocian, Carla ^a,b   Stadtmann, Anika ^a,c   Hermann, Sven ^a   Schäfers, Klaus ^a   Schäfers, Michael ^a   Iozzo, Renato V ^d   Zarbock, Alexander ^a,c   Götte, Martin ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; DECORIN; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; SYNDECAN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SHAPE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EAR DISEASE; ENDOTHELIUM; GLUCOSE METABOLISM; IMMUNOREGULATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MALE; MONONUCLEAR CELL; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SWELLING; WILD TYPE;

ANIMALS; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; DECORIN; DERMATITIS, CONTACT; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERSENSITIVITY, DELAYED; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, KNOCKOUT; NEUTROPHILS; POSITRON-EMISSION TOMOGRAPHY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNDECAN-1; TOMOGRAPHY, X-RAY COMPUTED;

EID: 82755189232     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100373     Document Type: Article

References (56)

1. Grabbe, S., and T. Schwarz. 1998. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19: 37-44. (Pubitemid 28078607)
2. Abbas, A. K. 2005. Cell-mediated (type IV) hypersensitivity. In Pathologic Basis of Disease, 7th Ed., V. Kumar, A. K. Abbas, and N. Fausto, eds. Elsevier Saunders, Philadelphia, p. 216-217.
3. Vestweber, D. 2007. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol. Rev. 218: 178-196. (Pubitemid 47052303)
4. Götte, M. 2003. Syndecans in inflammation. FASEB J. 17: 575-591. (Pubitemid 37221142)
5. Parish, C. R. 2006. The role of heparan sulphate in inflammation. Nat. Rev. Immunol. 6: 633-643. (Pubitemid 44298213)
6. Taylor, K. R., and R. L. Gallo. 2006. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 20: 9-22. (Pubitemid 43100470)
7. Rops, A. L., M. Götte, M. H. Baselmans, M. J. van den Hoven, E. J. Steenbergen, J. F. Lensen, T. J. Wijnhoven, F. Cevikbas, L. P. van den Heuvel, T. H. van Kuppevelt, et al. 2007. Syndecan-1 deficiency aggravates anti-glomerular basement membrane nephritis. Kidney Int. 72: 1204-1215. (Pubitemid 350059661)
8. Kharabi Masouleh, B., G. B. Ten Dam, M. K. Wild, R. Seelige, J. van der Vlag, A. L. Rops, F. G. Echtermeyer, D. Vestweber, T. H. van Kuppevelt, L. Kiesel, and M. Götte. 2009. Role of the heparan sulfate proteoglycan syndecan-1 (CD138) in delayed-type hypersensitivity. J. Immunol. 182: 4985-4993.
9. Floer, M., M. Götte, M. K. Wild, J. Heidemann, E. S. Gassar, W. Domschke, L. Kiesel, A. Luegering, and T. Kucharzik. 2010. Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice. Am. J. Pathol. 176: 146-157.
10. Kawashima, H., K. Atarashi, M. Hirose, J. Hirose, S. Yamada, K. Sugahara, and M. Miyasaka. 2002. Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J. Biol. Chem. 277: 12921-12930. (Pubitemid 34952659)
11. Seidler, D. G., J. Peter-Katalinić, and A. D. Zamfir. 2007. Galactosaminoglycan function and oligosaccharide structure determination. ScientificWorldJournal 7: 233-241. (Pubitemid 46294535)
12. Penc, S. F., B. Pomahac, E. Eriksson, M. Detmar, and R. L. Gallo. 1999. Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1. J. Clin. Invest. 103: 1329-1335. (Pubitemid 29218303)
13. Reed, C. C., and R. V. Iozzo. 2002. The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj. J. 19: 249-255. (Pubitemid 37174552)
14. Schaefer, L., and R. V. Iozzo. 2008. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J. Biol. Chem. 283: 21305-21309.
15. Kalamajski, S., and A. Oldberg. 2010. The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol. 29: 248-253.
16. Schönherr, E., C. Sunderkötter, R. V. Iozzo, and L. Schaefer. 2005. Decorin, a novel player in the insulin-like growth factor system. J. Biol. Chem. 280: 15767-15772. (Pubitemid 40616696)
17. Feugaing, D. D., R. Tammi, F. G. Echtermeyer, H. Stenmark, H. Kresse, M. Smollich, E. Schönherr, L. Kiesel, and M. Götte. 2007. Endocytosis of the dermatan sulfate proteoglycan decorin utilizes multiple pathways and is modulated by epidermal growth factor receptor signaling. Biochimie 89: 637-657. (Pubitemid 46669780)
18. Goldoni, S., A. Humphries, A. Nyström, S. Sattar, R. T. Owens, D. J. McQuillan, K. Ireton, and R. V. Iozzo. 2009. Decorin is a novel antagonistic ligand of the Met receptor. J. Cell Biol. 185: 743-754.
19. Fiedler, L. R., E. Schönherr, R. Waddington, S. Niland, D. G. Seidler, D. Aeschlimann, and J. A. Eble. 2008. Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of alpha2beta1 integrin activity. J. Biol. Chem. 283: 17406-17415.
20. Santra, M., D. M. Mann, E. W. Mercer, T. Skorski, B. Calabretta, and R. V. Iozzo. 1997. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Invest. 100: 149-157. (Pubitemid 27311253)
21. Seidler, D. G., S. Goldoni, C. Agnew, C. Cardi, M. L. Thakur, R. T. Owens, D. J. McQuillan, and R. V. Iozzo. 2006. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J. Biol. Chem. 281: 26408-26418. (Pubitemid 44401849)
22. Nelimarkka, L., H. Salminen, T. Kuopio, S. Nikkari, T. Ekfors, J. Laine, L. Pelliniemi, and H. Järveläinen. 2001. Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am. J. Pathol. 158: 345-353. (Pubitemid 32158595)
23. Danielson, K. G., H. Baribault, D. F. Holmes, H. Graham, K. E. Kadler, and R. V. Iozzo. 1997. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136: 729-743. (Pubitemid 27083772)
24. Järveläinen, H., P. Puolakkainen, S. Pakkanen, E. L. Brown, M. Höök, R. V. Iozzo, E. H. Sage, and T. N. Wight. 2006. A role for decorin in cutaneous wound healing and angiogenesis. Wound Repair Regen. 14: 443-452. (Pubitemid 44266601)
25. Schaefer, L., K. Macakova, I. Raslik, M. Micegova, H. J. Gröne, E. Schönherr, H. Robenek, F. G. Echtermeyer, S. Grässel, P. Bruckner, et al. 2002. Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am. J. Pathol. 160: 1181-1191. (Pubitemid 34224603)
26. Stepp, M. A., H. E. Gibson, P. H. Gala, D. D. Iglesia, A. Pajoohesh-Ganji, S. Pal-Ghosh, M. Brown, C. Aquino, A. M. Schwartz, O. Goldberger, et al. 2002. Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse. J. Cell Sci. 115: 4517-4531. (Pubitemid 36004412)
27. Seidler, D. G., L. Schaefer, H. Robenek, R. V. Iozzo, H. Kresse, and E. Schönherr. 2005. A physiologic three-dimensional cell culture system to investigate the role of decorin in matrix organisation and cell survival. Biochem. Biophys. Res. Commun. 332: 1162-1170. (Pubitemid 40798206)
28. Zamfir, A. D., C. Flangea, E. Sisu, A. F. Serb, N. Dinca, P. Bruckner, and D. G. Seidler. 2009. Analysis of novel over- and under-sulfated glycosaminoglycan sequences by enzyme cleavage and multiple stage MS. Proteomics 9: 3435-3444.
29. Bixel, M. G., B. Petri, A. G. Khandoga, A. Khandoga, K. Wolburg-Buchholz, H. Wolburg, S. März, F. Krombach, and D. Vestweber. 2007. A CD99-related antigen on endothelial cells mediates neutrophil but not lymphocyte extravasation in vivo. Blood 109: 5327-5336. (Pubitemid 46890554)
30. Zarbock, A., T. L. Deem, T. L. Burcin, and K. Ley. 2007. Galphai2 is required for chemokine-induced neutrophil arrest. Blood 110: 3773-3779. (Pubitemid 350159648)
31. Zarbock, A., C. L. Abram, M. Hundt, A. Altman, C. A. Lowell, and K. Ley. 2008. PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR gamma to induce slow leukocyte rolling. J. Exp. Med. 205: 2339-2347.
32. Mueller, H., A. Stadtmann, H. Van Aken, E. Hirsch, D. Wang, K. Ley, and A. Zarbock. 2010. Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) gamma2 and PI3Kgamma pathways. Blood 115: 3118-3127.
33. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(2Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
34. Vanhoutte, D., M. W. Schellings, M. Götte, M. Swinnen, V. Herias, M. K. Wild, D. Vestweber, E. Chorianopoulos, V. Cortés, A. Rigotti, et al. 2007. Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction. Circulation 115: 475-482. (Pubitemid 46184199)
35. Stelljes, M., S. Hermann, J. Albring, G. Köhler, M. Löffler, C. Franzius, C. Poremba, V. Schlösser, S. Volkmann, C. Opitz, et al. 2008. Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography. Blood 111: 2909-2918.
36. Ahlfors, E., R. Jonsson, and C. Czerkinsky. 1996. Experimental T cell-mediated inflammatory reactions in the murine oral mucosa. II. Immunohistochemical characterization of resident and infiltrating cells. Clin. Exp. Immunol. 104: 297-305. (Pubitemid 26139778)
37. Götte, M., A. M. Joussen, C. Klein, P. Andre, D. D. Wagner, M. T. Hinkes, B. Kirchhof, A. P. Adamis, and M. Bernfield. 2002. Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature. Invest. Ophthalmol. Vis. Sci. 43: 1135-1141. (Pubitemid 34258284)
38. McDermott, S. P., E. A. Ranheim, V. S. Leatherberry, S. S. Khwaja, K. S. Klos, and C. M. Alexander. 2007. Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development. Oncogene 26: 1407-1416. (Pubitemid 46340817)
39. Engeman, T., A. V. Gorbachev, D. D. Kish, and R. L. Fairchild. 2004. The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites. J. Leukoc. Biol. 76: 941-949. (Pubitemid 39458706)
40. Yamada, H., M. Matsukura, T. Yudate, J. Chihara, G. Stingl, and T. Tezuka. 1997. Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes. Int. Arch. Allergy Immunol. 114 (Suppl. 1): 28-32. (Pubitemid 27455062)
41. Zarbock, A., C. A. Lowell, and K. Ley. 2007. Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1. Immunity 26: 773-783. (Pubitemid 46907666)
42. Cunha, T. M., W. A. Verri, Jr., D. A. Valério, A. T. Guerrero, L. G. Nogueira, S. M. Vieira, D. G. Souza, M. M. Teixeira, S. Poole, S. H. Ferreira, and F. Q. Cunha. 2008. Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in mice. Eur. J. Pain 12: 1059-1068.
43. Montesano, R., M. S. Pepper, U. Möhle-Steinlein, W. Risau, E. F. Wagner, and L. Orci. 1990. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 62: 435-445.
44. Seidler, D. G., and R. Dreier. 2008. Decorin and its galactosaminoglycan chain: extracellular regulator of cellular function? IUBMB Life 60: 729-733.
45. Winnemöller, M., P. Schön, P. Vischer, and H. Kresse. 1992. Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment. Eur. J. Cell Biol. 59: 47-55.
46. Schaefer, L., A. Babelova, E. Kiss, H. J. Hausser, M. Baliova, M. Krzyzankova, G. Marsche, M. F. Young, D. Mihalik, M. Götte, et al. 2005. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 115: 2223-2233. (Pubitemid 41134165)
47. Marchica, C. L., V. Pinelli, M. Borges, J. Zummer, V. Narayanan, R. V. Iozzo, and M. S. Ludwig. 2011. A role for decorin in a murine model of allergen-induced asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 300: L863-L873.
48. Lee, S., K. Bowrin, A. R. Hamad, and S. Chakravarti. 2009. Extracellular matrix lumican deposited on the surface of neutrophils promotes migration by binding to beta2 integrin. J. Biol. Chem. 284: 23662-23669.
49. Ferdous, Z., V. M. Wei, R. V. Iozzo, M. Höök, and K. J. Grande-Allen. 2007. Decorin-transforming growth factor- interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices. J. Biol. Chem. 282: 35887-35898. (Pubitemid 350277129)
50. Ferdous, Z., S. B. Peterson, H. Tseng, D. K. Anderson, R. V. Iozzo, and K. J. Grande-Allen. 2010. A role for decorin in controlling proliferation, adhesion, and migration of murine embryonic fibroblasts. J. Biomed. Mater. Res. A 93: 419-428.
51. Dressler, J., L. Bachmann, M. Kasper, J. G. Hauck, and E. Müller. 1997. Time dependence of the expression of ICAM-1 (CD 54) in human skin wounds. Int. J. Legal Med. 110: 299-304. (Pubitemid 27475674)
52. Ohno, N., H. Ichikawa, L. Coe, P. R. Kvietys, D. N. Granger, and J. S. Alexander. 1997. Soluble selectins and ICAM-1 modulate neutrophil-endothelial adhesion and diapedesis in vitro. Inflammation 21: 313-324. (Pubitemid 27367832)
53. Muller, W. A. 2011. Mechanisms of leukocyte transendothelial migration. Annu. Rev. Pathol. 6: 323-344.
54. Coombe, D. R., S. M. Stevenson, B. F. Kinnear, N. S. Gandhi, R. L. Mancera, R. I. Osmond, and W. C. Kett. 2008. Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 2. Biochemical analyses. Biochemistry 47: 4863-4875. (Pubitemid 351574993)
55. DeLisser, H. M., H. C. Van, P. J. Newman, W. A. Muller, C. A. Buck, and S. M. Albelda. 1993. Platelet/endothelial cell adhesion molecule-I (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. J. Biol. Chem. 268: 16037-16046. (Pubitemid 23222111)
56. Yeaman, C., and A. C. Rapraeger. 1993. Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages. J. Cell Biol. 122: 941-950. (Pubitemid 23241103)